Abstract
Clinical laboratory (lab) tests are used in clinical practice to diagnose, treat, and monitor disease conditions. Test results are typically stored in electronic health records (EHRs), and a growing number of EHRs are linked to patient DNA, offering unprecedented opportunities to query relationships between clinical lab tests and genetics. Clinical lab data, however, are of uneven quality, and previous studies have focused on a small number of lab traits. We present two methods, QualityLab and LabWAS, to clean and analyze EHR labs at scale in a Lab-Wide Association Scan. In a proof of concept analysis focused on blood lipids and coronary artery disease, we found that heritability estimates of QualityLab lipid values were comparable to previous reports; polygenic scores for lipids were strongly associated with the referent lipid in a LabWAS; and a LabWAS of a polygenic score for coronary artery disease recapitulated known heart disease biomarker profiles and identified novel associations. Our methods extend previous EHR-based analysis tools and increase the amount of EHR data usable for discovery.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
JKD is supported by the Canadian Institutes of Health Research (award MFE- 142936). JMS is supported by NIH/NIGMS training grant 5T32GM080178-12. JDM is supported by AHA grant 16FTF30130005 and NIH GM130791-01. GC is supported by NIH UL1TR000427 and 1U24CA242637-01. LKD is supported by NIH 1R01MH118233-01, 5U54MD010722-04, 5R01MH113362-03, 1R56MH120736-01. This project was conducted in part using the resources of the Advanced Computing Center for Research and Education at Vanderbilt University, Nashville, TN. The datasets used for this project were obtained from Vanderbilt University Medical Center’s Synthetic Derivative, which is supported by numerous sources: institutional funding, private agencies, and federal grants. These include the NIH funded Shared Instrumentation Grant S10RR025141; and CTSA grants UL1TR002243, UL1TR000445, and UL1RR024975.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
GWAS data is available for data on the linked Dropbox website. Code is available here: QualityLab: https://bitbucket.org/straubp_vandy/quality_labs/ LabWAS: https://bitbucket.org/juliasealock/labwas/
https://www.dropbox.com/sh/w1pbe0jq1bjkpc5/AAAUIdtBgUybE6iHraE8jvp8a?dl=0